Literature DB >> 29777707

Functional analysis of juxta- and intra-membrane domains of murine APP by genome editing in Neuro2a cells.

Nanaka Kaneshiro1, Ryosuke Imaoka1, Masato Komai1, Taku Kashiyama2, Takashi Sakurai2, Takashi Uehara1, Nobumasa Takasugi3.   

Abstract

Amyloid-β precursor protein (APP) correlates with the pathogenesis of certain brain diseases, such as Alzheimer disease (AD). APP is cleaved by several enzymes to produce APP metabolites, including the amyloid beta peptide (Aβ), which accumulates in the brain of AD patients. However, the exact functions of APP metabolites remain elusive. In this study, using genome editing technology, we mutated juxta- and intra-membrane domains of murine APP in the mouse neuroblastoma cell line, Neuro2a. We identified several clones that expressed characteristic patterns of APP metabolites. Mutations in juxta- (deletion 673A), and intra-membrane (deletion 705-6LM) domains of APP, decreased overall levels of APP metabolites or decreased the level of α-secretase-cleaved carboxy-terminal fragment (αCTF), respectively. APP is known to influence neuronal differentiation; therefore, we used theses clones to dissect the function of APP metabolites during neuronal differentiation. One clone (CA), which expressed reduced levels of both FL-APP and αCTF, showed increased expression of the neuronal marker, β3-tubulin, and enhanced retinoic acid (RA)-induced neurite outgrowth. In contrast, a clone that expressed FL-APP, but was devoid of αCTF (CE), showed comparable expression of β3-tubulin and neurite outgrowth compared with normal Neuro2a cells. These data indicate that FL-APP is a suppressor of neurite outgrowth. Our data suggest a novel regulatory function of juxta- and intra-membrane domains on the metabolism and function of APP.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Amyloid beta; Amyloid precursor protein; Neurite outgrowth

Mesh:

Substances:

Year:  2018        PMID: 29777707     DOI: 10.1016/j.bbrc.2018.05.102

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer's disease.

Authors:  Nanaka Kaneshiro; Masato Komai; Ryosuke Imaoka; Atsuya Ikeda; Yuji Kamikubo; Takashi Saito; Takaomi C Saido; Taisuke Tomita; Tadafumi Hashimoto; Takeshi Iwatsubo; Takashi Sakurai; Takashi Uehara; Nobumasa Takasugi
Journal:  iScience       Date:  2022-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.